 Bank of New York Mellon Corp trimmed its stake in shares of Kiniksa Pharmaceuticals Ltd NASDAQ:KNSA by 11.5 in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission SEC. The firm owned 46,224 shares of the companys stock after selling 5,989 shares during the ... 